Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Dendritic Cell Cancer Vaccine Market Research Report 2016

  • QYR720463
  • 106 Pages
  • October 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Dendritic Cell Cancer Vaccine

Revenue, means the sales value of Dendritic Cell Cancer Vaccine

This report studies Dendritic Cell Cancer Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

3M Company

Activartis

Batavia Bioservices

Creagene

Dendreon

Merck

Northwest Biotherapeutics

Glaxo Smith Kline

ImmunoCellular Therapeutics

Tella Incorporation

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Dendritic Cell Cancer Vaccine in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

CreaVax

Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)

Provenge

Split by application, this report focuses on consumption, market share and growth rate of Dendritic Cell Cancer Vaccine in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global Dendritic Cell Cancer Vaccine Market Research Report 2016

1 Dendritic Cell Cancer Vaccine Market Overview

1.1 Product Overview and Scope of Dendritic Cell Cancer Vaccine

1.2 Dendritic Cell Cancer Vaccine Segment by Type

1.2.1 Global Production Market Share of Dendritic Cell Cancer Vaccine by Type in 2015

1.2.2 CreaVax

1.2.3 Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)

1.2.4 Provenge

1.3 Dendritic Cell Cancer Vaccine Segment by Application

1.3.1 Dendritic Cell Cancer Vaccine Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Dendritic Cell Cancer Vaccine Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Dendritic Cell Cancer Vaccine (2011-2021)

2 Global Dendritic Cell Cancer Vaccine Market Competition by Manufacturers

2.1 Global Dendritic Cell Cancer Vaccine Production and Share by Manufacturers (2015 and 2016)

2.2 Global Dendritic Cell Cancer Vaccine Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Dendritic Cell Cancer Vaccine Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Dendritic Cell Cancer Vaccine Manufacturing Base Distribution, Sales Area and Product Type

2.5 Dendritic Cell Cancer Vaccine Market Competitive Situation and Trends

2.5.1 Dendritic Cell Cancer Vaccine Market Concentration Rate

2.5.2 Dendritic Cell Cancer Vaccine Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Dendritic Cell Cancer Vaccine Production, Revenue (Value) by Region (2011-2016)

3.1 Global Dendritic Cell Cancer Vaccine Production and Market Share by Region (2011-2016)

3.2 Global Dendritic Cell Cancer Vaccine Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Dendritic Cell Cancer Vaccine Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Dendritic Cell Cancer Vaccine Consumption by Regions (2011-2016)

4.2 North America Dendritic Cell Cancer Vaccine Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Dendritic Cell Cancer Vaccine Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Dendritic Cell Cancer Vaccine Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Dendritic Cell Cancer Vaccine Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Dendritic Cell Cancer Vaccine Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Dendritic Cell Cancer Vaccine Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Dendritic Cell Cancer Vaccine Production, Revenue (Value), Price Trend by Type

5.1 Global Dendritic Cell Cancer Vaccine Production and Market Share by Type (2011-2016)

5.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2011-2016)

5.3 Global Dendritic Cell Cancer Vaccine Price by Type (2011-2016)

5.4 Global Dendritic Cell Cancer Vaccine Production Growth by Type (2011-2016)

6 Global Dendritic Cell Cancer Vaccine Market Analysis by Application

6.1 Global Dendritic Cell Cancer Vaccine Consumption and Market Share by Application (2011-2016)

6.2 Global Dendritic Cell Cancer Vaccine Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Dendritic Cell Cancer Vaccine Manufacturers Profiles/Analysis

7.1 3M Company

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 3M Company Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Activartis

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Activartis Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Batavia Bioservices

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 Creagene

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Creagene Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Dendreon

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Dendreon Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Merck

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Merck Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Northwest Biotherapeutics

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Glaxo Smith Kline

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 ImmunoCellular Therapeutics

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 Tella Incorporation

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 Tella Incorporation Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

8 Dendritic Cell Cancer Vaccine Manufacturing Cost Analysis

8.1 Dendritic Cell Cancer Vaccine Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Dendritic Cell Cancer Vaccine Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Dendritic Cell Cancer Vaccine Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Dendritic Cell Cancer Vaccine Market Forecast (2016-2021)

12.1 Global Dendritic Cell Cancer Vaccine Production, Revenue Forecast (2016-2021)

12.2 Global Dendritic Cell Cancer Vaccine Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Dendritic Cell Cancer Vaccine Production Forecast by Type (2016-2021)

12.4 Global Dendritic Cell Cancer Vaccine Consumption Forecast by Application (2016-2021)

12.5 Dendritic Cell Cancer Vaccine Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Dendritic Cell Cancer Vaccine

Figure Global Production Market Share of Dendritic Cell Cancer Vaccine by Type in 2015

Figure Product Picture of CreaVax

Table Major Manufacturers of CreaVax

Figure Product Picture of Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)

Table Major Manufacturers of Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)

Figure Product Picture of Provenge

Table Major Manufacturers of Provenge

Table Dendritic Cell Cancer Vaccine Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America Dendritic Cell Cancer Vaccine Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Dendritic Cell Cancer Vaccine Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Dendritic Cell Cancer Vaccine Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Dendritic Cell Cancer Vaccine Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Dendritic Cell Cancer Vaccine Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Dendritic Cell Cancer Vaccine Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Dendritic Cell Cancer Vaccine Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Dendritic Cell Cancer Vaccine Production of Key Manufacturers (2015 and 2016)

Table Global Dendritic Cell Cancer Vaccine Production Share by Manufacturers (2015 and 2016)

Figure 2015 Dendritic Cell Cancer Vaccine Production Share by Manufacturers

Figure 2016 Dendritic Cell Cancer Vaccine Production Share by Manufacturers

Table Global Dendritic Cell Cancer Vaccine Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers

Table 2016 Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers

Table Global Market Dendritic Cell Cancer Vaccine Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Dendritic Cell Cancer Vaccine Average Price of Key Manufacturers in 2015

Table Manufacturers Dendritic Cell Cancer Vaccine Manufacturing Base Distribution and Sales Area

Table Manufacturers Dendritic Cell Cancer Vaccine Product Type

Figure Dendritic Cell Cancer Vaccine Market Share of Top 3 Manufacturers

Figure Dendritic Cell Cancer Vaccine Market Share of Top 5 Manufacturers

Table Global Dendritic Cell Cancer Vaccine Production by Regions (2011-2016)

Figure Global Dendritic Cell Cancer Vaccine Production and Market Share by Regions (2011-2016)

Figure Global Dendritic Cell Cancer Vaccine Production Market Share by Regions (2011-2016)

Figure 2015 Global Dendritic Cell Cancer Vaccine Production Market Share by Regions

Table Global Dendritic Cell Cancer Vaccine Revenue by Regions (2011-2016)

Table Global Dendritic Cell Cancer Vaccine Revenue Market Share by Regions (2011-2016)

Table 2015 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Regions

Table Global Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Table China Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Table India Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Dendritic Cell Cancer Vaccine Consumption Market by Regions (2011-2016)

Table Global Dendritic Cell Cancer Vaccine Consumption Market Share by Regions (2011-2016)

Figure Global Dendritic Cell Cancer Vaccine Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Dendritic Cell Cancer Vaccine Consumption Market Share by Regions

Table North America Dendritic Cell Cancer Vaccine Production, Consumption, Import & Export (2011-2016)

Table Europe Dendritic Cell Cancer Vaccine Production, Consumption, Import & Export (2011-2016)

Table China Dendritic Cell Cancer Vaccine Production, Consumption, Import & Export (2011-2016)

Table Japan Dendritic Cell Cancer Vaccine Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Dendritic Cell Cancer Vaccine Production, Consumption, Import & Export (2011-2016)

Table India Dendritic Cell Cancer Vaccine Production, Consumption, Import & Export (2011-2016)

Table Global Dendritic Cell Cancer Vaccine Production by Type (2011-2016)

Table Global Dendritic Cell Cancer Vaccine Production Share by Type (2011-2016)

Figure Production Market Share of Dendritic Cell Cancer Vaccine by Type (2011-2016)

Figure 2015 Production Market Share of Dendritic Cell Cancer Vaccine by Type

Table Global Dendritic Cell Cancer Vaccine Revenue by Type (2011-2016)

Table Global Dendritic Cell Cancer Vaccine Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Dendritic Cell Cancer Vaccine by Type (2011-2016)

Figure 2015 Revenue Market Share of Dendritic Cell Cancer Vaccine by Type

Table Global Dendritic Cell Cancer Vaccine Price by Type (2011-2016)

Figure Global Dendritic Cell Cancer Vaccine Production Growth by Type (2011-2016)

Table Global Dendritic Cell Cancer Vaccine Consumption by Application (2011-2016)

Table Global Dendritic Cell Cancer Vaccine Consumption Market Share by Application (2011-2016)

Figure Global Dendritic Cell Cancer Vaccine Consumption Market Share by Application in 2015

Table Global Dendritic Cell Cancer Vaccine Consumption Growth Rate by Application (2011-2016)

Figure Global Dendritic Cell Cancer Vaccine Consumption Growth Rate by Application (2011-2016)

Table 3M Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 3M Company Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure 3M Company Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Activartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Activartis Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure Activartis Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Batavia Bioservices Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Batavia Bioservices Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure Batavia Bioservices Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Creagene Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Creagene Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure Creagene Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Dendreon Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Dendreon Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure Dendreon Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure Merck Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Northwest Biotherapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Glaxo Smith Kline Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure Glaxo Smith Kline Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table ImmunoCellular Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Tella Incorporation Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Tella Incorporation Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

Figure Tella Incorporation Dendritic Cell Cancer Vaccine Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Dendritic Cell Cancer Vaccine

Figure Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine

Figure Dendritic Cell Cancer Vaccine Industrial Chain Analysis

Table Raw Materials Sources of Dendritic Cell Cancer Vaccine Major Manufacturers in 2015

Table Major Buyers of Dendritic Cell Cancer Vaccine

Table Distributors/Traders List

Figure Global Dendritic Cell Cancer Vaccine Production and Growth Rate Forecast (2016-2021)

Figure Global Dendritic Cell Cancer Vaccine Revenue and Growth Rate Forecast (2016-2021)

Table Global Dendritic Cell Cancer Vaccine Production Forecast by Regions (2016-2021)

Table Global Dendritic Cell Cancer Vaccine Consumption Forecast by Regions (2016-2021)

Table Global Dendritic Cell Cancer Vaccine Production Forecast by Type (2016-2021)

Table Global Dendritic Cell Cancer Vaccine Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370